Martin Gadsby Redefines PAT for Manufacturing Environments

    Martin Gadsby Redefines PAT for Manufacturing Environments

    For years, gurus have suggested that the P in PAT should be emphasized, to focus on process understanding rather than the analytics and technology involved.  Success has been mixed.  Maybe it was asking too much of people to think first of their processes?  Should it be framed in less idealistic and more pragmatic and business-oriented terms? In an article outlining a structured and practical approach to applying PAT to manufacturing environments, Martin Gadsby, Director of Optimal Automation, Ltd., redefines the three-letter acronym, as the “practical application of technology.”   Here is his article, recently published on PharmaManufacturing.com.

    Related posts:

    1. Drug Manufacturing: Still Waiting for the Sea Change?
      Pharmaceutical Manufacturing's April cover story asks the question, have we made real and tangible progress in the past decade?...
    2. QbD Classics: Process Modeling and Control in Drug Development and Manufacturing
      An impressive collection of articles on the latest modeling techniques, edited by Pfizer's Salvador García Muñoz and Cynthia Oksanen....
    3. GSK, GEA, Siemens: Changing Drug Manufacturing’s Clock Speed
      A Proof of Feasibility pilot seeks to accelerate the manufacture of solid oral dosage product via continuous processes and PAT....
    4. Ajaz Hussain on the State of Pharmaceutical Manufacturing
      The progress of Quality by Design and other key industry initiatives is slow, says Ajaz Hussain, CSO at Philip Morris...
    5. Pharmaceutical Manufacturing eBook: Holistic QbD
      This e-book offers general resources in the area of QbD, and discusses how West Pharmaceuticals has been bringing a QbD...

    Leave a Reply

    You must be logged in to post a comment.